BEADI - The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information (BEADI)
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
BEADI is a dissemination trial, on standards of care of premature babies. The main objective of BEADI is to assess whether an innovative 'active' strategy for the dissemination of neonatal information (evidence reviews, interactive training workshop, benchmarking and feedback, and ongoing support) is more likely to lead to changes in policy and practice than the traditional (more passive) forms of dissemination in English neonatal units.
BEADI will focus on three areas of neonatal care for premature (22+0 to 26+6 weeks' gestation) babies born in England: timing of surfactant therapy, staffing for resuscitation at delivery, and temperature control (in line with the main Project 27/28 findings ). However, the approach is applicable to a wide variety of clinical policies and practice.
The BEADI study has been granted ethical approval by MREC to use a subset of data collected by EPICure2 up until 31st December 2006 (pre-intervention data). For the post-intervention data, ethical approval has been granted for CEMACH to continue data collection against the three clinical areas using a subset of data items captured in the PN:E2 form, for the three month period between 1st January - 31st March 2007. Local research and development departments of each trust have also been contacted.
| Condition | Intervention | Phase |
|---|---|---|
|
Premature Babies |
Behavioral: Effects of Active Dissemination |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | The Bliss Cluster Randomised Control Trial on the Effects of Active Dissemination of Information on Outcomes of Premature Babies. |
- Assess whether an innovative 'active' strategy for the dissemination of neonatal research findings, recs and national guidelines is more likely to lead to changes in policy and practice than the traditional,passive forms of dissemination in the UK. [ Time Frame: 3 years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 200 |
| Study Start Date: | October 2005 |
| Estimated Study Completion Date: | March 2009 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
-
Behavioral: Effects of Active Dissemination
Eligibility| Ages Eligible for Study: | 22 Weeks to 27 Weeks |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Hospital staff : Lead neonatologist for clinical governance in each maternity hospital in England.
- Babies born in England before 27 weeks gestation between January 2006 - 31st March 2007
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00831168
| Principal Investigator: | Dominique Acolet | Confidential Enquiry into Maternal and Child Health |
More Information
No publications provided
| Responsible Party: | Richard Congdon, CEMACH |
| ClinicalTrials.gov Identifier: | NCT00831168 History of Changes |
| Other Study ID Numbers: | BEADI2005 |
| Study First Received: | January 27, 2009 |
| Last Updated: | January 27, 2009 |
| Health Authority: | England: The Confidential Enquiry into Maternal and Child Health |
Keywords provided by Confidential Enquiry into Maternal and Child Health:
|
neonatal premature babies healthcare research Babies born before 27 weeks gestation |
ClinicalTrials.gov processed this record on February 27, 2015